European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

32 EU fundings (€15.7M): Personalized disease prediction and prevention in chronic inflammatory disorders … BdlYear 2024 EU Research and Innovation programme "Horizon"

Text

Crossroads Bank for Enterprises (KBO) 0456.343.923

01/08/2024 EU funding (€1,378,273): Implementing wastewater and environmental surveillance for Mpox in Sub-Saharan Africa
11/09/2024 EU funding (€1,497,740): Probing the malignant potential of mutant clones in healthy mammary tissue by successive mutagenesis
24/09/2024 EU funding (€1,499,650): Immune mechanisms of experience induced brain plasticity: the contribution of brain resident T cells
30/09/2024 EU funding (€1,500,000): Building emotional circuits: interfacing intrinsic programs with early-life experiences
05/02/2024 EU funding (€1,999,756): Drug DELIvery to the brain via CHOroid Plexus targeting
15/11/2024 EU funding (€11M): Personalized disease prediction and prevention in chronic inflammatory disorders
28/07/2024 EU funding (€150,000): A nanobody imaging tool to detect protein crystals and predict therapeutic response in asthmatics
01/09/2024 EU funding (€150,000): Gamma-secretase allosteric modulation as preventive therapy in Alzheimer’s Disease
18/01/2024 EU funding (€150,000): LNP-DECODE: Broadening the therapeutic window of LNP-based vaccination
08/01/2024 EU funding (€150,000): Making time-resolved cryo-EM available for the community of structural biologists: validate, improve, derisk
08/01/2024 EU funding (€150,000): Targeting eicosanoid metabolism to overcome tumor immunosuppression
07/03/2024 EU funding (€175,920): A function for sleep-dependent tau dynamics
24/04/2024 EU funding (€175,920): Changing the tempo of neuronal development to modulate neural circuit function and plasticity
11/03/2024 EU funding (€175,920): Developing CRISPR activation/CRISPR interference toolset for fine-tuning production of metabolites in plants
14/03/2024 EU funding (€175,920): Extracellular Vesicles as mediators of Pre-Metastatic Niche Formation in Melanoma
08/03/2024 EU funding (€175,920): Innate behavioral modulations across different life stages
18/03/2024 EU funding (€175,920): REPHASE: REdox regulation of PHAse separation for plant Adaptation to Stressful Environments
14/03/2024 EU funding (€175,920): Reprogramming eNdOthelial cells in immune-COLD tuMORs
12/04/2024 EU funding (€175,920): Unraveling Brassinosteroid Biosynthesis: Orchestrating BR Precursor Movement via Endoplasmic Reticulum-Plasma Membrane Contact Sites (EPCSs)
29/04/2024 EU funding (€191,760): Age-dependent nutrient priming of the pre-metastatic niche
11/03/2024 EU funding (€191,760): DEmystifying Targets in Endothelial Cells for anti-Tumor Immunity improVEments
02/05/2024 EU funding (€191,760): Measuring all cells of Drosophila development to reconstruct differentiation trajectories and understand the language of the genome
07/03/2024 EU funding (€191,760): Structural, kinetic, and biophysical analysis and engineering of KIT.METRNL signalling to boost heart tissue regeneration after myocardial infarction
16/03/2024 EU funding (€191,760): Tracer Raman-Driven Mass Spectrometry Imaging (TRaMaSI): a new platform for on-tissue Tracing of Nutritional and Biochemical Trajectories
11/03/2024 EU funding (€191,760): Unravelling interactions between fermentable carbohydrates and the gut microbiota in patients with IBS
19/06/2024 EU funding (€2,254,766): Harnessing the DNA Damage Response to improve plant tolerance to heat stress
23/05/2024 EU funding (€2,499,674): Allosteric modulation of immune checkpoint complexes as a new mode of therapeutic intervention in immunotherapy
08/07/2024 EU funding (€2,637,950): Integrated multi-angle research and training network to eradicate leukemia minimal residual disease
01/01/2024 EU funding (€3,903,826): Quality, Utility and Maturity Measured; Developing a Data Quality and Utility Label for HealthData@EU
30/08/2024 EU funding (€56.3M): EUROPEAN RARE DISEASES RESEARCH ALLIANCE
12/11/2024 EU funding (€7,285,044): Comparative signature of Marburg virus cell activation as a blueprint for the identification of antiviral targets against newly emerging viruses
01/01/2024 EU funding (€7,999,839): Evolvable and rapidly adaptable monobodies: a broad-spectrum antiviral platform

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Vlaams Instituut Voor Biotechnologie - Flanders Institute for Biotechnology VZW, Ghent, Belgium.

Creative Commons License The visualizations for "32 EU fundings (€15.7M): Personalized disease prediction and prevention in chronic inflammatory disorders …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.